KIT and gastrointestinal stromal tumor: Third, because tumor size, metabolic tumor volume, or pathological characteristics, all of which are potential indicators that could influence ctDNA positivity in GIST, have not been evaluated, their impact on ctDNA positivity or KIT mutational status could not be assessed in this study.